Paracetamolo Galenica Senese (Paracetamol)

Paracetamol works by inhibiting cyclooxygenase enzymes, especially COX‑2, within the central nervous system. This reduces the production of prostaglandins that sensitize pain receptors and reset the hypothalamic set‑point for temperature, providing analgesic and antipyretic effects without significant peripheral anti‑inflammatory activity.

The exact dose and infusion rate are determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and total daily paracetamol exposure. Healthcare professionals follow local guidelines and consider liver function, renal status, and any concomitant medications before setting the regimen.

Safety data for intravenous paracetamol during pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Clinicians should weigh potential benefits against risks and consult current obstetric guidelines before prescribing to pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and any required import documentation.

The primary alternative to intravenous paracetamol is intravenous ibuprofen, which adds anti‑inflammatory activity but carries higher gastrointestinal and renal risk. Compared with oral formulations, the IV route offers faster onset and reliable plasma levels, useful when oral intake is not feasible or rapid effect is required.

Paracetamolo Galenica Senese must be stored at 2‑8 °C in a refrigerator. It should be kept in its original container, protected from light, and must not be frozen or shaken vigorously. Once removed from refrigeration, the solution should be used within the time frame specified by the manufacturer.

The product is administered intravenously, typically as a slow infusion over 15 minutes to 30 minutes, depending on clinical protocol. Administration should be performed by qualified healthcare personnel using aseptic technique, and the infusion line should be monitored for signs of hypersensitivity or hemodynamic changes.

The most serious risks include severe hepatic injury, especially when total daily dose exceeds recommended limits, and rare but life‑threatening hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome. Prompt recognition of liver enzyme elevations or allergic signs is essential for patient safety.

Patients with known hypersensitivity to paracetamol or any excipients, those with severe hepatic impairment, and individuals who have exceeded the maximum daily paracetamol dose should avoid this product. Caution is also advised for patients with unstable cardiovascular status due to the potential for transient hypotension during infusion.